MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'hahan, N.
Right arrow Articles by Vivaudou, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'hahan, N.
Right arrow Articles by Vivaudou, M.

Vol. 56, Issue 2, 308-315, August 1999

A Transmembrane Domain of the Sulfonylurea Receptor Mediates Activation of ATP-Sensitive K+ Channels by K+ Channel Openers

Nathalie D'hahan, Hélène Jacquet, Christophe Moreau, Patrice Catty, and Michel Vivaudou

Laboratoire de Biophysique Moleculaire et Celluraire, Département de Biologie Moléculaire et Structurale, Commissariat à l'Energie Atomique, Grenoble, France

ATP-sensitive K+ (KATP) channels are a complex of an ATP-binding cassette transporter, the sulfonylurea receptor (SUR), and an inward rectifier K+ channel subunit, Kir6.2. The diverse pharmacological responsiveness of KATP channels from various tissues are thought to arise from distinct SUR isoforms. Thus, when assembled with Kir6.2, the pancreatic beta  cell isoform SUR1 is activated by the hyperglycemic drug diazoxide but not by hypotensive drugs like cromakalim, whereas the cardiac muscle isoform SUR2A is activated by cromakalim and not by diazoxide. We exploited these differences between SUR1 and SUR2A to pursue a chimeric approach designed to identify the structural determinants of SUR involved in the pharmacological activation of KATP channels. Wild-type and chimeric SUR were coexpressed with Kir6.2 in Xenopus oocytes, and we studied the resulting channels with the patch-clamp technique in the excised inside-out configuration. The third transmembrane domain of SUR is found to be an important determinant of the response to cromakalim, which possibly harbors at least part of its binding site. Contrary to expectations, diazoxide sensitivity could not be linked specifically to the carboxyl-terminal end (nucleotide-binding domain 2) of SUR but appeared to involve complex allosteric interactions between transmembrane and nucleotide-binding domains. In addition to providing direct evidence for the structure-function relationship governing KATP channel activation by potassium channel-opening drugs, a family of drugs of the highest therapeutic interest, these findings delineate the determinants of ligand specificity within the modular ATP-binding cassette-transporter architecture of SUR.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
H. Kinoshita, M. Dojo, K. Nakahata, Y. Kimoto, T. Kakutani, K. Mizumoto, and Y. Hatano
Augmented activity of adenosine triphosphate-sensitive k+ channels induced by droperidol in the rat aorta.
Anesth. Analg., March 1, 2006; 102(3): 786 - 791.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
W. Yang, G. Yang, X. Jia, L. Wu, and R. Wang
Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms
J. Physiol., December 1, 2005; 569(2): 519 - 531.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Moreau, F. Gally, H. Jacquet-Bouix, and M. Vivaudou
The Size of a Single Residue of the Sulfonylurea Receptor Dictates the Effectiveness of KATP Channel Openers
Mol. Pharmacol., April 1, 2005; 67(4): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Kinoshita, T. Azma, K. Nakahata, H. Iranami, Y. Kimoto, M. Dojo, O. Yuge, and Y. Hatano
Inhibitory Effect of High Concentration of Glucose on Relaxations to Activation of ATP-Sensitive K+ Channels in Human Omental Artery
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2290 - 2295.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Hambrock, T. Kayar, D. Stumpp, and H. Osswald
Effect of Two Amino Acids in TM17 of Sulfonylurea Receptor SUR1 on the Binding of ATP-Sensitive K+ Channel Modulators
Diabetes, December 1, 2004; 53(suppl_3): S128 - S134.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A.-L. Prost, A. Bloc, N. Hussy, R. Derand, and M. Vivaudou
Zinc is both an intracellular and extracellular regulator of KATP channel function
J. Physiol., August 15, 2004; 559(1): 157 - 167.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. D. Mironova, A. E. Negoda, B. S. Marinov, P. Paucek, A. D. T. Costa, S. M. Grigoriev, Y. Yu. Skarga, and K. D. Garlid
Functional Distinctions between the Mitochondrial ATP-dependent K+ Channel (mitoKATP) and Its Inward Rectifier Subunit (mitoKIR)
J. Biol. Chem., July 30, 2004; 279(31): 32562 - 32568.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Davis-Taber, E. J. Molinari, R. J. Altenbach, K. L. Whiteaker, C.-C. Shieh, G. Rotert, S. A. Buckner, J. Malysz, I. Milicic, J. S. McDermott, et al.
[125I]A-312110, a Novel High-Affinity 1,4-Dihydropyridine ATP-sensitive K+ Channel Opener: Characterization and Pharmacology of Binding
Mol. Pharmacol., July 1, 2003; 64(1): 143 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Cartier, S. Shen, and S.-L. Shyng
Modulation of the Trafficking Efficiency and Functional Properties of ATP-sensitive Potassium Channels through a Single Amino Acid in the Sulfonylurea Receptor
J. Biol. Chem., February 21, 2003; 278(9): 7081 - 7090.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Poitry, L. van Bever, F. Coppex, A. Roatti, and A. J Baertschi
Differential sensitivity of atrial and ventricular KATP channels to metabolic inhibition
Cardiovasc Res, February 1, 2003; 57(2): 468 - 476.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Dabrowski, F. M. Ashcroft, R. Ashfield, P. Lebrun, B. Pirotte, J. Egebjerg, J. Bondo Hansen, and P. Wahl
The Novel Diazoxide Analog 3-Isopropylamino-7-Methoxy-4H-1,2,4-Benzothiadiazine 1,1-Dioxide Is a Selective Kir6.2/SUR1 Channel Opener
Diabetes, June 1, 2002; 51(6): 1896 - 1906.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Reimann, F. M. Ashcroft, and F. M. Gribble
Structural Basis for the Interference Between Nicorandil and Sulfonylurea Action
Diabetes, October 1, 2001; 50(10): 2253 - 2259.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
H. Kinoshita, H. Iranami, Y. Kimoto, M. Dojo, and Y. Hatano
Cibenzoline Has an Inhibitory Effect on Vasorelaxation Mediated by Adenosine Triphosphate-Sensitive K+ Channels in the Rat Carotid Artery
Anesth. Analg., August 1, 2001; 93(2): 282 - 286.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. Reimann, F. M. Gribble, and F. M. Ashcroft
Differential Response of KATP Channels Containing SUR2A or SUR2B Subunits to Nucleotides and Pinacidil
Mol. Pharmacol., April 13, 2001; 58(6): 1318 - 1325.
[Abstract] [Full Text]


Home page
FASEB J.Home page
M. BIENENGRAEBER, A. E. ALEKSEEV, M. R. ABRAHAM, A. J. CARRASCO, C. MOREAU, M. VIVAUDOU, P. P. DZEJA, and A. TERZIC
ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex
FASEB J, October 1, 2000; 14(13): 1943 - 1952.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. P. Babenko, G. Gonzalez, and J. Bryan
Pharmaco-topology of Sulfonylurea Receptors. SEPARATE DOMAINS OF THE REGULATORY SUBUNITS OF KATP CHANNEL ISOFORMS ARE REQUIRED FOR SELECTIVE INTERACTION WITH K+ CHANNEL OPENERS
J. Biol. Chem., January 14, 2000; 275(2): 717 - 720.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. D'hahan, C. Moreau, A.-L. Prost, H. Jacquet, A. E. Alekseev, A. Terzic, and M. Vivaudou
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP
PNAS, October 12, 1999; 96(21): 12162 - 12167.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Malhi, A. N. Irani, P. Rajvanshi, S. O. Suadicani, D. C. Spray, T. V. McDonald, and S. Gupta
KATP Channels Regulate Mitogenically Induced Proliferation in Primary Rat Hepatocytes and Human Liver Cell Lines. IMPLICATIONS FOR LIVER GROWTH CONTROL AND POTENTIAL THERAPEUTIC TARGETING
J. Biol. Chem., August 18, 2000; 275(34): 26050 - 26057.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Matsuo, K. Tanabe, N. Kioka, T. Amachi, and K. Ueda
Different Binding Properties and Affinities for ATP and ADP among Sulfonylurea Receptor Subtypes, SUR1, SUR2A, and SUR2B
J. Biol. Chem., September 8, 2000; 275(37): 28757 - 28763.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics